Patent classifications
B01J13/043
Encapsulation system for prolonged release of active agents
The present technology generally relates to an encapsulation system for delivery of an active agent, the encapsulation system comprising a matrix of microcapsules, wherein a first portion of microcapsules in the matrix of microcapsules has an average diameter of from about 0.1 microns to about 10 microns; a second portion of the microcapsules has an average diameter of from about 10 microns to about 100 microns; and a third portion of the microcapsules has an average diameter of from about 100 microns to about 500 microns; and wherein the active agent is encapsulated in the microcapsules.
COMPOSITIONS, SYSTEMS, AND METHODS OF MAKING AND USING ENCAPSULATED LYOPHILISED MICROSPHERES
The present disclosure relates to a composition comprising a shell surrounding a core, wherein the core comprises one or more lyophilised microspheres. Also described herein is a method comprising providing one or more lyophilised microspheres; and coating the one or more lyophilised microspheres with a shell under conditions effective to encapsulate the one or more lyophilised microspheres. The present disclosure further relates to a system comprising one or more composition as described herein, and one or more lyophilised cake, wherein the one or more composition and the one or more lyophilised cake are combined under conditions effective to form a rehydration system. Also described herein is a method of controlling release of one or more encapsulated microspheres comprising providing a composition as described herein and mixing the composition with a rehydration solution under a first condition effective to control release of one or more lyophilised microspheres from the composition.
Porous metal oxide microspheres with varying pore sizes
Porous metal oxide microspheres are prepared via a process comprising forming a liquid solution or dispersion of polydisperse polymer nanoparticles and a metal oxide; forming liquid droplets from the solution or dispersion; drying the liquid droplets to provide polymer template microspheres comprising polymer nanospheres and metal oxide; and removing the polymer nanospheres from the template microspheres to provide the porous metal oxide microspheres. The porous microspheres exhibit saturated colors and are suitable as colorants for a variety of end-uses.
Method for obtaining encapsulated nanoparticles
A method for obtaining at least one particle, including: (a) preparing solution A including at least one precursor of at least one of Si, B, P, Ge, As, Al, Fe, Ti, Zr, Ni, Zn, Ca, Na, Ba, K, Mg, Pb, Ag, V, Te, Mn, Ir, Sc, Nb, Sn, Ce, Be, Ta, S, Se, N, F, and Cl; (b) preparing aqueous solution B; (c) forming droplets of solution A; (d) forming droplets of solution B; (e) mixing droplets; (f) dispersing mixed droplets in a gas flow; (g) heating dispersed droplets to obtain the at least one particle; (h) cooling the at least one particle; and (i) separating and collecting the at least one particle. The aqueous solution is acidic, neutral, or basic. In step (a) and/or step (b) at least one colloidal suspension of a plurality of nanoparticles is mixed with the solution. Also, a device for implementing the method.
COMPOSITE PARTICLE AND METHOD OF FORMING SAME
The present invention relates to a method of forming a composite particle, a composite particle precursor formulation, a composite particle, and a composite material comprising a plurality of composite particles. The method of forming a composite particle may include the step of: contacting an active material particle, a modified oligomeric metal coordination complex, and at least one polymer, to thereby form a composite particle.
COMPOSITE PHASE-CHANGE MATERIALS WITH ACTIVE SUPPORTING MEDIA FOR THERMAL ENERGY STORAGE APPLICATIONS
A composite phase-change material (PCM) has a non-polymeric solid-solid PCM and a solid-liquid PCM. The solid-liquid PCM occupies an internal volume of the solid-solid PCM. The composite material takes full advantage of the latent heat of both PCMs, while avoiding seepage of the inner solid-liquid PCM. A method is for the preparation of the composite PCM. A thermal energy storage device includes the composite PCM.
COMPOSITION COMPRISING SELF-STRATIFYING AMPHIPHILIC JANUS PARTICLES
The disclosure relates to a composition comprising amphiphilic Janus particles and a waterborne binder, wherein the particles are self-stratified, and methods of making and using the same. The disclosure also relates to the synthesis of amphiphilic Janus particles.
Polyurea capsules cross-linked with chitosan
An improved process of forming polyurea and chitosan microcapsules encapsulating a benefit agent is described. The process comprises forming a water phase comprising hydrolyzing chitosan in an acidic medium at a pH of 6.5 or less for an extended period and combining with a polyisocyanate. The reaction product of the hydrolyzed chitosan and polyisocyanate yields a microcapsule having improved release characteristics, with enhanced degradation characteristics in OECD test method 301B.
POLYSACCHARIDE DELIVERY PARTICLE
Disclosed are: (a) controlled release matrix particles containing 10-70 wt. % of a hydrophobic active ingredient, 21-72 wt. % of a polysaccharide, 3.80-12 wt. % of a crosslinking agent, 1.00-6 wt. % of a catalyst and 0.10-5 wt. % of a silica flow aid; (b) controlled release core/shell particles containing 10-70 wt. % of a hydrophobic active ingredient, 1.0-3.2 wt. % of an epoxidized oil, 21-64 wt. % of a polysaccharide, 7.6-23% of an amine-functionality containing material, and 0.10-5 wt. % of a silica flow aid; and (c) hybrid particles wherein the core/shell particles are contained in a matrix. Also disclosed are methods for making the particles and compositions containing the particles.
METHODS OF FORMING PARTICLES BY CONTINUOUS DROPLET FORMATION AND DEHYDRATION
The present disclosure relates to methods that enable the continuous formation of droplets and dehydration of droplets to provide pharmaceutically relevant particles that can be used for therapy. In particular, the methods disclosed herein allow the controlled continuous droplet formation and dehydration that produce circular particles having low internal void spaces comprising bioactive therapeutic biologies.